Kevin McVary, MD

Financial relationships

  • Attribution:
    Self
    Type of financial relationship:
    Scientific Study or Trial (General Urology)
    Ineligible company:
    Astellas
    Date added:
    Date updated:
    10/02/2023
  • Attribution:
    Self
    Type of financial relationship:
    Scientific Study or Trial (Oncology)
    Ineligible company:
    Francis Medical
    Date added:
    Date updated:
    10/02/2023
  • Attribution:
    Self
    Type of financial relationship:
    Scientific Study or Trial (General Urology)
    Ineligible company:
    Urotronic
    Date added:
    Date updated:
    10/02/2023
  • Attribution:
    Self
    Type of financial relationship:
    Scientific Study or Trial (Male Genitourinary Reconstruction/Trauma)
    Ineligible company:
    Olympus
    Date added:
    Date updated:
    10/02/2023
  • Attribution:
    Self
    Type of financial relationship:
    Scientific Study or Trial (General Urology)
    Ineligible company:
    NxThera
    Date added:
    Date updated:
    10/02/2023
  • Attribution:
    Self
    Type of financial relationship:
    Consultant or Advisor (Specialty Not Specified)
    Ineligible company:
    Olympus
    Date added:
    Date updated:
    10/02/2023
  • Attribution:
    Self
    Type of financial relationship:
    Health Publishing (Specialty Not Specified)
    Ineligible company:
    SRS Medical Systems
    Date added:
    Date updated:
    10/02/2023
  • Attribution:
    Self
    Type of financial relationship:
    Scientific Study or Trial (Specialty Not Specified)
    Ineligible company:
    NIDDK
    Date added:
    Date updated:
    10/02/2023
  • Attribution:
    Self
    Type of financial relationship:
    Consultant or Advisor (Specialty Not Specified)
    Ineligible company:
    Merck
    Date added:
    Date updated:
    10/02/2023
Return to Update Series (2022) Lesson 12: 5-Alpha Reductase Inhibitor Therapy for Benign Prostatic Hyperplasia